Big Gain For Altimmune, Inc.
Wed, Jun 16, 2021 at 05:30 PM
Altimmune, Inc. (ALT:NASDAQ) rocketted at $16.46, a gain of 16.5%. On Tue, Jun 15, 2021, ALT:NASDAQ touched a New 2-Week Intraday High of $15.44. The stock got featured on our News Catalysts scanner on Wed, Jun 16, 2021 at 10:16 AM in the 'BIOTECH' category. From Tue, Jun 01, 2021, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Feb 18, 2021 at $24.61 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Altimmune, Inc. (ALT:NASDAQ)
Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.
Top 10 Gainers:
- ORPH (ORPH:NASDAQ), 61.29%
- Kindred Biosciences, Inc. (KIN:NASDAQ), 45.58%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 21.45%
- UTME (UTME:NASDAQ), 20.41%
- GTT Communications, Inc. (GTT:NYSE), 20%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 18.95%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 18.15%
- OPT (OPT:NASDAQ), 17.48%
- AUVI (AUVI:NASDAQ), 17.39%
- Altimmune, Inc. (ALT:NASDAQ), 16.49%